Expression of epidermal growth factor receptor in oral and esophageal squamous-cell carcinoma

Squamous-cell carcinoma (SCC) represents the most common type of malignancies in the oral cavity (O) and esophagus (E). Epidermal growth factor receptor (EGFR) plays a key role in numerous processes that affects tumor growth, progression, differentiation, invasion, metastasis, and inhibition of apop...

Full description

Saved in:
Bibliographic Details
Published in:Dental research journal 2020-03, Vol.17 (2), p.85-91
Main Authors: Shahsavari, Fatemeh, Miri, Rosa, Ghorbanpour, Maedeh
Format: Article
Language:English
Subjects:
Apoptosis
Cancer metastasis
Carcinoma
Development and progression
Epidermal growth factor
Epidermal growth factor receptors
Epidermal growth factors
Esophageal cancer
Esophagus
Metastases
Oral cancer
Oral cavity
Original
Paraffin
Squamous cell carcinoma
Statistical analysis
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Squamous-cell carcinoma (SCC) represents the most common type of malignancies in the oral cavity (O) and esophagus (E). Epidermal growth factor receptor (EGFR) plays a key role in numerous processes that affects tumor growth, progression, differentiation, invasion, metastasis, and inhibition of apoptosis. In this study, we wanted to investigate the EGFR expression in OSCC and ESCC cases. As well, another purpose was to observe if there exists any relation between its expression and clinicopathologic factors. To the best of our knowledge, this is the first study which compares the EGFR protein expression between OSCC and ESCC. This cross-sectional study was performed on 46 paraffin blocks (23 OSCC and 23 ESCC). The expression of EGFR was evaluated with immunohistochemical technique. Data analyses were done using SPSS software by Fisher's exact test. Significance was assigned at < 0.05. Out of 46 patients, 25 cases (54.3%) were male and 21 (45.7%) were female. Seventy-eight percent of OSCCs and 73.9% of ESCCs showed high expression of EGFR. No statistically significant difference was observed between the two groups ( = 0.73). There were no statistically significant correlations between EGFR expression and clinicopathologic factors (age, gender, grade, and stage) of OSCCs ( > 0.05). A statistically significant correlation was found between EGFR expression and stage in ESCCs group ( = 0.006). No significant correlation was found between the expression of EGFR protein in OSCCs and ESCCs. High expression of EGFR was observed in ESCCs with Stages II, III.
ISSN:1735-3327
2008-0255
DOI:10.4103/1735-3327.280890